Immunodeficiency 34; Imd34
Description
IMD34 results in predisposition to infections by poorly virulent mycobacteria, such as bacillus Calmette-Guerin (BCG) vaccines and nontuberculous environmental bacteria. Affected individuals are also susceptible to the more virulent species Mycobacterium tuberculosis (Bustamante et al., 2007).
Clinical Features
Phenotypes and symptoms related to Immunodeficiency 34; Imd34
- Recurrent infections
- Recurrent mycobacterial infections
- Severe recurrent varicella
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Immunodeficiency 34; Imd34 Is also known as atypical mycobacteriosis, familial, x-linked 2, amcbx2, immunodeficiency 34, mycobacteriosis, x-linked.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Immunodeficiency 34; Imd34 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
100 % |
![]() By Children's Hospital Colorado Molecular Genetics Laboratory Children's Hospital Colorado (United States).
CYBB
Specificity
100 %
Genes
100 % |
![]() By Molecular Diagnostic Laboratory University of Alberta (Canada).
CYBB
Specificity
100 %
Genes
100 % |
![]() By Molecular Diagnostic Laboratory University of Alberta (Canada).
CYBB
Specificity
100 %
Genes
100 % |
![]() By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
CYBB
Specificity
100 %
Genes
100 % |
![]() By ARUP Laboratories, Molecular Genetics and Genomics (United States).
CYBB, NCF1
Specificity
50 %
Genes
100 % |
![]() By ARUP Laboratories, Molecular Genetics and Genomics (United States).
CYBB
Specificity
100 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
CYBB
Specificity
100 %
Genes
100 % |
You can get up to 31 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like THROMBOCYTHEMIA 1; THCYT1 SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J CHROMOSOME 15q14 DELETION SYNDROME ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9